BBIL to fund expansion through private placement of sharesIllustrative image – not actual.

Bharat Biotech International Ltd (BBIL) plans to raise Rs.100 crore through private placement of shares to fund its expansion plan.

 

The company’s expansion plan envisages setting up a new manufacturing facility near Hyderabad. The funds raised through the private placement will also be used to set up a sales and marketing network and undertake research and development in pharmacogenomics.

 

Presently, the promoters hold 60 per cent of the company’s equity and financial institutions and non-resident Indians hold the remaining 40 per cent equity. The promoters’ equity would be reduced to 50 per cent after the private placement.

← All latest storiesBack to top →